C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2004
12/22/2004	EP1121363B1 6-SUBSTITUTED PYRAZOLO(3,4-d)PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556807A Chemical compounds
12/22/2004	CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004	CN1181074C Method for preparing tri-ethyl-di-amine (TEDA)
12/22/2004	CN1181073C Method for producing triethylene diamine using ethylene diamine
12/21/2004	US6833454 Chemical compounds containing bis(triazolo)triazine structures and methods thereof
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833371 Contacting cell with a sodium channel-inhibiting amount of a compound comprising a pyrazolopyrimidine moiety for decreasing ion flow through a voltage-dependent sodium channel in a cell
12/16/2004	WO2004108731A1 Beta-strand mimetics and method relating thereto
12/16/2004	WO2004108730A1 1h-imidazo`4,5-d!pyridazines as dpp-iv inhibitors for the treatment of niddm
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108728A1 Cannabinoid receptor ligands and uses thereof
12/16/2004	WO2004108727A1 Triazolopyrimidines
12/16/2004	WO2004108726A1 2-SUBSTITUTED PHENYL-5,7-DIALKYL-3,7-DIHYDROPYRROLE [2,3-d] PYRIMIDINE-4-ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
12/16/2004	WO2004108722A1 Orthocondensed polycyclic aminopyrrole derivatives comprising an electro-attractive substituent, combination products of said derivatives, and method for the production thereof
12/16/2004	WO2004108671A1 Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
12/16/2004	WO2004108668A2 Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use
12/16/2004	WO2004108280A1 Method for increasing the cutting hardness of a molded body
12/16/2004	WO2004108136A1 Triazolo `1 , 5-a!pyrimidines and their use in medicine
12/16/2004	WO2004107863A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
12/16/2004	WO2004076449A3 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/16/2004	WO2004072029A3 Pyrazolopyridazines useful as inhibitors of protein kinases
12/16/2004	WO2003105538A8 Electroluminescent device
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254205 Phenalene derivatives
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254187 5-ethyl-imidazotriazinones
12/16/2004	US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
12/16/2004	US20040254181 Process for the preparation of 9-deazaguanine derivatives
12/16/2004	US20040254166 Substituted phenyl acetamides and their use as protease inhibitors
12/16/2004	DE10323345A1 Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren New Pyridopyrazine and their use as kinase inhibitors
12/16/2004	CA2525752A1 Cannabinoid receptor ligands and uses thereof
12/16/2004	CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/15/2004	EP1486498A1 Process and intermediates for growth hormone secretagogues
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485386A2 Pyridinyloxy derivatives as 5-ht receptor ligands
12/15/2004	EP1485385A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004	EP1430033A4 Anti-inflammatory and protein kinase inhibitor composition and method of use
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1109816A4 Vinyl substituted cyclic products of the ene-yne reaction
12/15/2004	EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/15/2004	EP0988263B1 Process for the production of radioiodinated neuroreceptor agents
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555378A Process for preparation of amidine derivatives
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1554657A Total synthesizing meethod for pyrrole heterocyclic alkaloid aldisin
12/15/2004	CN1554656A Yunnan tolal biological coronaridine and its salts and preparing method and use
12/14/2004	US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added)
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831074 Inhibitors of cyclic guanosine 3',5'-monophosphate phosphodiesterases (cGMP PDES); for use in therapy of sexual disorders
12/14/2004	US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/14/2004	US6831061 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them
12/14/2004	CA2235146C Herbicidal sulfonamides
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004	CA2136075C Heterocyclic ether compounds that enhance cognitive function
12/09/2004	WO2004106492A2 Bicyclicpyrimidones and their use to treat diseases
12/09/2004	WO2004106436A1 Phthalocyanine compounds
12/09/2004	WO2004106343A2 Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
12/09/2004	WO2004106342A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
12/09/2004	WO2004106341A1 Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds
12/09/2004	WO2004106340A2 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
12/09/2004	WO2004106339A2 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
12/09/2004	WO2004106305A1 New p2x7 receptor antagonists and their use
12/09/2004	WO2004106294A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
12/09/2004	WO2004105700A2 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/09/2004	WO2004092173A3 A2a adenosine receptor antagonists
12/09/2004	WO2004075863A3 Cxcr3 antagonists
12/09/2004	WO2004063151A3 Novel tyrosine kinase inhibitors
12/09/2004	US20040249162 From a pyrrolidinone compound; coloring high molecular weight material
12/09/2004	US20040249148 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248912 4- (4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo [2,3D] pyrimidine hydrogen mesylate, its polymorphic forms, and methods for making same
12/09/2004	US20040248911 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumor
12/09/2004	US20040248905 6-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
12/09/2004	US20040248900 Endothelial nitric oxide synthase expression stimulants; cardiovascular disorders
12/09/2004	US20040248898 Group V and/or X secretory phospholipase A2 inhibition; suppressing degeneration of serum lipoproteins
12/09/2004	US20040248895 Novel guanidino compounds
12/09/2004	US20040248892 Low cost, simple, high yield and purity synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles; oxidative cyclization of bisindolylmaleimide compounds
12/09/2004	US20040248891 Imidazotriazinone-containing compositions for nasal administration
12/09/2004	US20040248890 Voltage gated sodium and calcium channel inhibitors
12/09/2004	US20040248881 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
12/09/2004	US20040248880 Radioligands; diagnosing anxiety, depression, central nervous system disorders; tomography
12/09/2004	US20040248879 Phosphate salt of 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one; water solubility; potentiation of anticancer therapies; inhibition of neurotoxicity from stroke, head trauma and/or neurodegenerative diseases
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	US20040248779 subjecting a diene to metathesis cyclization reaction in the presence of a benzylidene ruthenium catalyst
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	US20040245183 Cationic phthalocyanine and/or porphyins salts used particularly for inactivating Gram-positive and Gram-negative bacteria, yeasts, micoplasmas and parasites; not only for drinking or irrigation water, but also water used in fields such as fish-farming
12/09/2004	CA2527420A1 Compounds, methods and pharmaceutical compositions for inhibiting parp

1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 573